WUTSUP-02-II-Neo-Dis-Tis: Investigating the efficacy and safety of neoadjuvant tislelizumab plus disitamab vedotin with adjuvant tislelizumab in upper urinary tract carcinoma—A phase II multi-center study.

Autor: Bao, Yige, Liao, Xinyang, Zhang, Peng, Zeng, Hao, Liu, Jiyan, Wei, Qiang
Zdroj: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS718-TPS718, 193p
Databáze: Supplemental Index